Navigation Links
Licensing Strategies of Large Pharmaceutical Companies - Weak R&D Pipelines and the Patent Cliff Stimulate In-Licensing Activity
Date:9/6/2011

and deal making landscape in pharmaceutical industry

- Trends in deals for product licensing and technology licensing agreements.

- Extensive research and analysis of the licensing activity of large pharmaceutical companies.

- Licensing and deal making segmentation of top 20 in the pharmaceutical companies by phase, type, geography and value

- Company profiles of leading biotech companies active in licensing and deal making

Reasons to buy

The report will enhance your decision making capability. It will allow you to -

- Develop market-entry and market expansion strategies by identifying the leading areas for licensing and deal making in the pharmaceutical industry.

- Enable better product lifecycle management by identifying key phases of product licensing agreements.

- Develop segment specific strategies for licensing and deal making in pharmaceutical industry.

- Develop key strategic initiatives by understanding the key licensing and deal making focus areas of leading pharma companies.

- Accelerate and strengthen your market position by identifying key companies for licensing agreements.

1 Table of Contents

1 Table of Contents 3

1.1 List of Tables 7

1.2 List of Figures 8

2 Licensing Strategies In Large Pharmaceutical Companies – Introduction 13

2.1 Licensing Agreement – An Authorization 13

2.2 GBI Research Report Guidance 15

3 Trends in In-licensing and Out-licensing Agreements 16

3.1 In-Licensing Compensates For Declining Internal R&D 16

3.2 Licensing Key To Combat Patent Cliff 16

3.3 Spiraling Cost of Licensing Deals 16

3.3.1 Competition to Restock Pipelines 16

3.3.2 Biotechs Push Products through Further Stages of Development 16

4 Product Licensing 18

4.1 Licensing Offsets Deficiencies in Internal Pipelines and Portfolios 18

4.2 Oncology Therapy Area Sp
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related medicine technology :

1. Beckman Coulter Announces Licensing Agreements for Molecular Tests with National University of Ireland, Galway
2. Lilly and Transition Therapeutics Announce Licensing and Collaboration Agreement
3. Orion Genomics Gains Exclusive Worldwide Rights to the IGF2 Gene for Colorectal Cancer Risk Testing Through Licensing Agreement With Johns Hopkins University
4. Lilly and TransPharma Medical Announce Licensing and Development Agreement
5. Genzyme and Isis Complete Licensing of Mipomersen
6. MabVax Therapeutics Closes Two Licensing Agreements With Sloan-Kettering Institute for Cancer Research
7. Lilly and Deciphera Pharmaceuticals Announce Licensing and Collaboration Agreement
8. CEL-SCI Announces Expansion of Exclusive Licensing Agreement for Cancer Drug Multikine
9. Ipsogen Expands its US Market Presence Through Licensing Agreement With ARUP Laboratories for the Commercialization of JAK2 Molecular Diagnostic Assays
10. Ironwood Announces Linaclotide European Licensing Agreement with Almirall
11. Addrenex Pharmaceuticals Expands Product Pipeline by Licensing New Drug to Treat Narcolepsy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... 18, 2013 Remedy Informatics, a leading ... life sciences research, today announced it has been ... Schedule 70 supply contract (GS-35F-367AA, effective May 7, ... IT solutions to government agencies at federal, state ... Remedy has placed its products and services on ...
(Date:6/18/2013)... , June 18, 2013  Pro football player and ... and professional family expert Jo Frost have ... Specialty L.P., the fully integrated specialty pharmaceutical business of ... awareness of this significant health problem. In recognition of ... and Drug Administration (FDA) approval of EpiPen ® ...
(Date:6/17/2013)... ANGELES , June 17, 2013 Velplex, ... TopProdeals.com , a technology platform that connects buyers and ... into being an industry leader. Why? ... at TopProdeals™ are intimately familiar with the dental industry. ... healthcare community and have diligently worked to negotiate some ...
Breaking Medicine Technology:Remedy Informatics Awarded GSA Contract to Provide Innovative IT Solutions to Federal, State and Local Agencies 2Remedy Informatics Awarded GSA Contract to Provide Innovative IT Solutions to Federal, State and Local Agencies 3Remedy Informatics Awarded GSA Contract to Provide Innovative IT Solutions to Federal, State and Local Agencies 4Mylan Specialty L.P. Joins Forces with Adrian Peterson and Jo Frost to Launch Anaphylaxis Preparedness Campaign 2Mylan Specialty L.P. Joins Forces with Adrian Peterson and Jo Frost to Launch Anaphylaxis Preparedness Campaign 3Mylan Specialty L.P. Joins Forces with Adrian Peterson and Jo Frost to Launch Anaphylaxis Preparedness Campaign 4Mylan Specialty L.P. Joins Forces with Adrian Peterson and Jo Frost to Launch Anaphylaxis Preparedness Campaign 5Mylan Specialty L.P. Joins Forces with Adrian Peterson and Jo Frost to Launch Anaphylaxis Preparedness Campaign 6Mylan Specialty L.P. Joins Forces with Adrian Peterson and Jo Frost to Launch Anaphylaxis Preparedness Campaign 7Mylan Specialty L.P. Joins Forces with Adrian Peterson and Jo Frost to Launch Anaphylaxis Preparedness Campaign 8TopProdeals.com Rises to Top as Discount Dental Supply Leader 2
... Resources, one of the world,s leading research and advisory ... insulins and insulin analogues stand to erode $6.1 billion ... Germany, Italy, Spain and U.K.) by 2018, saving healthcare ... insulins are relatively easy to develop and manufacture, the ...
... , WASHINGTON, Oct. 14 The exhibit hall at ... E. Washington Convention Center is brimming with displays of ... of research and development in the MedTech industry, and ... care of people all over the world. The ...
Cached Medicine Technology:Biosimilar Insulins and Insulin Analogues Stand to Erode $6.1 Billion in Brand Sales in the U.S. and Europe by 2018 2Biosimilar Insulins and Insulin Analogues Stand to Erode $6.1 Billion in Brand Sales in the U.S. and Europe by 2018 3Vibrant Exhibit Hall Features Innovative Medical Technology at AdvaMed 2009 2
(Date:6/18/2013)... shown that cancer cells have a much different ... scientists at The University of Texas at Dallas have ... strategy to combat lung cancer. , In an article ... ONE , UT Dallas researchers compared the metabolic characteristics ... taken from the same patient. , They found ...
(Date:6/18/2013)... new commercial venture, using technology developed at Case ... and Case School of Engineering, has made available ... allows graduate students and others training to evaluate ... program, reducing stress on the trainee, because a ... real person. , Graduate students studying to ...
(Date:6/18/2013)... June 18, 2013 More than 1.1 million ... with HIV/AIDS, according to the Centers for Disease Control and ... are infected. In support of National HIV Testing Day on ... Disability Insurance (SSDI) representation, the CDC and other organizations ... , The CDC reports about 50,000 new HIV infections each ...
(Date:6/18/2013)... 2013 The Elizabeth Glaser Pediatric AIDS ... the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) ... new milestones in the global effort to eliminate pediatric ... that as of June 2013, one million babies globally ... Since PEPFAR’s inception in 2003, EGPAF has been a ...
(Date:6/18/2013)... 2013 Two months ago, Suyima Torres, 28, ... for a second session of a silicone treatment for gluteus ... treatment was allegedly performed by a mystery Venezuelan doctor in ... According to Dr. Bernabe Vazquez of Bayshore Cosmetic Surgery ... from doctor’s who are not board certified is more common ...
Breaking Medicine News(10 mins):Health News:UT Dallas study suggests new approach to fight lung cancer 2Health News:UT Dallas study suggests new approach to fight lung cancer 3Health News:SimuCase avatars advance speech-language pathology training 2Health News:Allsup Observes National HIV Testing Day June 27 2Health News:Allsup Observes National HIV Testing Day June 27 3Health News:One Million Babies Born HIV-free Signals Major Milestone in Global Effort to Eliminate Pediatric AIDS 2Health News:One Million Babies Born HIV-free Signals Major Milestone in Global Effort to Eliminate Pediatric AIDS 3Health News:Dr. Bernabe Vazquez Speaks on Miami Woman’s Deadly Silicone Butt Injection 2Health News:Dr. Bernabe Vazquez Speaks on Miami Woman’s Deadly Silicone Butt Injection 3
... the first FDA approval of a PEGylated Fab, fragment of ... humanized ... Food and,Drug Administration (FDA) approved UCB,s Cimzia(R) (certolizumab pegol) for,reducing ... in adult patients with moderate to severe active disease who ...
... PALO ALTO, Calif., April 23 Jazz,Pharmaceuticals, Inc. ... Cozadd, the,company,s Executive Chairman, will provide a corporate ... in Key Biscayne, FL,on May 1, 2008 at ... of the presentation may be accessed by visiting ...
... Information Technology to Meet Today,s Healthcare Challenges, ... Quantum Group,Inc. (AMEX: QGP, QGP.WSA, QGP.WSB) ... CEO, Noel J. Guillama has been asked ... Corporation,s 7th Annual Life,Science Conference, "Leveraging Information ...
... - Treat Yourself to EDY,S Winning American Idol Ice Cream and, Limited-edition ... ... Cause -, BOSTON, and OAKLAND, Calif., April 23 Everyone,s a,winner ... Day on Saturday, May 3 for the Triple Winner Game,Scoop(R) Day event., ...
... increased 18% to $1.09; ... fiscal year, FRANKLIN LAKES, N.J., April 23 ... reported record quarterly revenues,of $1.747 billion for the second ... 11 percent over the prior year period. This,quarter,s revenue ...
... Superior court dismisses illegal temporary restraining order ... publicity stunt, OAKLAND, Calif., April 22 ... order against the,Service Employees International Union (SEIU) and ... publicity stunt by the California Nurses Association,(CNA). The ...
Cached Medicine News:Health News:FDA Approval of Cimzia(R) for Crohn's Disease Represents Latest Milestone for Nektar's PEGylation Technology Platform 2Health News:FDA Approval of Cimzia(R) for Crohn's Disease Represents Latest Milestone for Nektar's PEGylation Technology Platform 3Health News:The Quantum Group CEO to Deliver Keynote Address at EDC Life Science Conference 2Health News:The Quantum Group CEO to Deliver Keynote Address at EDC Life Science Conference 3Health News:EDY'S(R) Slow Churned(R) and Stop & Shop Stores Announce Scoop Day With Sweet Deals to Support the Fight Against Childhood Cancer 2Health News:BD Announces Results for Second Fiscal Quarter 2Health News:BD Announces Results for Second Fiscal Quarter 3Health News:BD Announces Results for Second Fiscal Quarter 4Health News:BD Announces Results for Second Fiscal Quarter 5Health News:BD Announces Results for Second Fiscal Quarter 6Health News:BD Announces Results for Second Fiscal Quarter 7Health News:BD Announces Results for Second Fiscal Quarter 8Health News:BD Announces Results for Second Fiscal Quarter 9Health News:BD Announces Results for Second Fiscal Quarter 10Health News:BD Announces Results for Second Fiscal Quarter 11Health News:BD Announces Results for Second Fiscal Quarter 12Health News:BD Announces Results for Second Fiscal Quarter 13Health News:BD Announces Results for Second Fiscal Quarter 14Health News:BD Announces Results for Second Fiscal Quarter 15Health News:Court Throws Out Restraining Order Against SEIU 2Health News:Court Throws Out Restraining Order Against SEIU 3
... Quant™ 200 is a fixed wavelength ... 460 nm emission. The spectral characteristics ... of double-stranded DNA using the standard ... minimizes interference from the presence of ...
The VICTOR² D fluorometer is suitable for clinical assays based on fluorescence or time-resolved fluorescence from a wide variety of plates....
Liquid, ready-to-use, bar-coded Olympus reagents are convenient, economical easy-to-use and reliable. This is one of 122 tests standardized for use on the Olympus AU400e, AU640e, AU2700, and AU5400 C...
... neonate/pediatric blanket provides warmth to ... The blanket may be used ... with a drape that is ... patient to help retain heat. ...
Medicine Products: